Florian Schwoerer

Title: Florian Schwoerer: Innovator in Antigen Binding Proteins

Introduction

Florian Schwoerer is a notable inventor based in Tuebingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. His work focuses on innovative solutions for cancer diagnosis and treatment.

Latest Patents

Florian Schwoerer holds a patent for "Antigen binding proteins specifically binding PRAME." This invention concerns antigen binding proteins directed against PRAME protein-derived antigens. The patent provides antigen binding proteins that are specific for the tumor-expressed antigen PRAME, which is in a complex with a major histocompatibility complex (MHC) protein. The proteins contain complementary determining regions (CDRs) of engineered T cell receptors (TCRs) that specifically bind to the PRAME peptide. These proteins are intended for use in the diagnosis, treatment, and prevention of PRAME-expressing cancerous diseases. Additionally, the patent includes nucleic acids encoding the antigen binding proteins, vectors comprising these nucleic acids, recombinant cells expressing the proteins, and pharmaceutical compositions containing them. Florian Schwoerer has 1 patent to his name.

Career Highlights

Florian Schwoerer is associated with Immatics Biotechnologies GmbH, a company that focuses on developing innovative cancer immunotherapies. His work at Immatics has positioned him as a key player in the biotechnology sector, contributing to advancements in cancer treatment.

Collaborations

Florian collaborates with notable colleagues such as Gabriele Pszolla and Martin Hofmann. Their combined expertise enhances the research and development efforts at Immatics Biotechnologies GmbH.

Conclusion

Florian Schwoerer is a distinguished inventor whose work in antigen binding proteins has the potential to revolutionize cancer treatment. His contributions to biotechnology are significant and continue to impact the field positively.